Aesculus Bio ApS — Credit Rating and Financial Key Figures
Credit rating
Company information
About Aesculus Bio ApS
Aesculus Bio ApS (CVR number: 40560866) is a company from KØBENHAVN. The company recorded a gross profit of -13.6 kDKK in 2023. The operating profit was -13.6 kDKK, while net earnings were -10.9 kDKK. The profitability of the company measured by Return on Assets (ROA) was -4.8 %, which can be considered poor and Return on Equity (ROE) was -7.4 %, which can be considered poor. The equity ratio, a key indicator for solidity, stood at 52.4 %, a level that can be considered to be modest. This means a balanced mix of debt and equity financing its assets—a typical operational level for many companies. Aesculus Bio ApS's liquidity measured by quick ratio was 0.5 which is at a low level. Thus, the company may face difficulties in addressing its short-term obligations with its available liquid assets.
Financial information
See financialsGross profit (kDKK)
EBIT (kDKK)
Profitability
Solidity
Key figures (kDKK)
See financials2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|
Volume | |||||
Net sales | |||||
Gross profit | -12.17 | -11.74 | 87.68 | -25.02 | -13.63 |
EBIT | -12.17 | -11.74 | 87.68 | -25.02 | -13.63 |
Net earnings | -12.30 | -14.63 | 73.55 | -14.52 | -10.88 |
Shareholders equity total | 107.69 | 93.06 | 166.61 | 152.09 | 141.20 |
Balance sheet total (assets) | 136.39 | 206.98 | 408.04 | 300.40 | 269.71 |
Net debt | 21.70 | 104.68 | -87.71 | 28.55 | 62.47 |
Profitability | |||||
EBIT-% | |||||
ROA | -8.9 % | -6.8 % | 28.3 % | -5.1 % | -4.8 % |
ROE | -11.4 % | -14.6 % | 56.6 % | -9.1 % | -7.4 % |
ROI | -9.4 % | -7.1 % | 36.0 % | -6.5 % | -5.2 % |
Economic value added (EVA) | -12.17 | -13.13 | 73.64 | -12.58 | -9.87 |
Solvency | |||||
Equity ratio | 79.0 % | 45.0 % | 40.8 % | 50.6 % | 52.4 % |
Gearing | 20.1 % | 114.9 % | 70.2 % | 76.9 % | 82.8 % |
Relative net indebtedness % | |||||
Liquidity | |||||
Quick ratio | 0.0 | 0.0 | 0.8 | 0.7 | 0.5 |
Current ratio | 0.0 | 0.0 | 0.8 | 0.7 | 0.5 |
Cash and cash equivalents | 2.24 | 204.60 | 88.34 | 54.42 | |
Capital use efficiency | |||||
Trade debtors turnover (days) | |||||
Net working capital % | |||||
Credit risk | |||||
Credit rating | BB | BB | BB | BB | BB |
Variable visualization
Roles
Companies in the same industry
Create your own estimates for any company
Valuation analysis
See instructions

... and more!
No registration needed.